IBDEI30W ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48271,0)
 ;;=N83.9^^185^2420^38
 ;;^UTILITY(U,$J,358.3,48271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48271,1,3,0)
 ;;=3^Fallopion & Broad Ligament Noninflammatory Disorder of Ovary,Unspec
 ;;^UTILITY(U,$J,358.3,48271,1,4,0)
 ;;=4^N83.9
 ;;^UTILITY(U,$J,358.3,48271,2)
 ;;=^5015865
 ;;^UTILITY(U,$J,358.3,48272,0)
 ;;=N82.9^^185^2420^39
 ;;^UTILITY(U,$J,358.3,48272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48272,1,3,0)
 ;;=3^Fistulae,Female Genital Tract,Unspec
 ;;^UTILITY(U,$J,358.3,48272,1,4,0)
 ;;=4^N82.9
 ;;^UTILITY(U,$J,358.3,48272,2)
 ;;=^5015853
 ;;^UTILITY(U,$J,358.3,48273,0)
 ;;=N49.9^^185^2420^41
 ;;^UTILITY(U,$J,358.3,48273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48273,1,3,0)
 ;;=3^Genital Organ Inflammatory Disorder,Male,Unspec
 ;;^UTILITY(U,$J,358.3,48273,1,4,0)
 ;;=4^N49.9
 ;;^UTILITY(U,$J,358.3,48273,2)
 ;;=^5015749
 ;;^UTILITY(U,$J,358.3,48274,0)
 ;;=N50.9^^185^2420^40
 ;;^UTILITY(U,$J,358.3,48274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48274,1,3,0)
 ;;=3^Genital Organ Disorder,Male,Unspec
 ;;^UTILITY(U,$J,358.3,48274,1,4,0)
 ;;=4^N50.9
 ;;^UTILITY(U,$J,358.3,48274,2)
 ;;=^5015751
 ;;^UTILITY(U,$J,358.3,48275,0)
 ;;=N81.10^^185^2420^25
 ;;^UTILITY(U,$J,358.3,48275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48275,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,48275,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,48275,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,48276,0)
 ;;=R39.9^^185^2420^42
 ;;^UTILITY(U,$J,358.3,48276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48276,1,3,0)
 ;;=3^Genitourinary System,Unspec Signs/Symptoms
 ;;^UTILITY(U,$J,358.3,48276,1,4,0)
 ;;=4^R39.9
 ;;^UTILITY(U,$J,358.3,48276,2)
 ;;=^5019351
 ;;^UTILITY(U,$J,358.3,48277,0)
 ;;=R31.9^^185^2420^45
 ;;^UTILITY(U,$J,358.3,48277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48277,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,48277,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,48277,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,48278,0)
 ;;=R39.11^^185^2420^46
 ;;^UTILITY(U,$J,358.3,48278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48278,1,3,0)
 ;;=3^Hesitancy of Micturition
 ;;^UTILITY(U,$J,358.3,48278,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,48278,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,48279,0)
 ;;=N43.3^^185^2420^47
 ;;^UTILITY(U,$J,358.3,48279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48279,1,3,0)
 ;;=3^Hydrocele,Unspec
 ;;^UTILITY(U,$J,358.3,48279,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,48279,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,48280,0)
 ;;=N95.1^^185^2420^57
 ;;^UTILITY(U,$J,358.3,48280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48280,1,3,0)
 ;;=3^Menopausal & Female Climacteric States
 ;;^UTILITY(U,$J,358.3,48280,1,4,0)
 ;;=4^N95.1
 ;;^UTILITY(U,$J,358.3,48280,2)
 ;;=^5015927
 ;;^UTILITY(U,$J,358.3,48281,0)
 ;;=N95.9^^185^2420^58
 ;;^UTILITY(U,$J,358.3,48281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48281,1,3,0)
 ;;=3^Menopausal & Perimenopausal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48281,1,4,0)
 ;;=4^N95.9
 ;;^UTILITY(U,$J,358.3,48281,2)
 ;;=^5015929
 ;;^UTILITY(U,$J,358.3,48282,0)
 ;;=R35.1^^185^2420^61
 ;;^UTILITY(U,$J,358.3,48282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48282,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,48282,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,48282,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,48283,0)
 ;;=N45.2^^185^2420^62
 ;;^UTILITY(U,$J,358.3,48283,1,0)
 ;;=^358.31IA^4^2
